* MiMedx Group Inc MDXG.OQ MDXG.O is expected to show a
rise
in quarterly revenue when it reports results on July 31 for the
period ending June 30 2024
* The Marietta Georgia-based company is expected to report
a
9.4% increase in revenue to $88.919 million from $81.26 million
a year ago, according to the mean estimate from 7 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for MiMedx Group Inc is for
earnings of 8 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for MiMedx
Group Inc
is $12.00, above its last closing price of $7.76.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jan. 1 0001 0.04 0.05 0.07 Beat 55.6
Dec. 31 0001 0.07 0.07 0.32 Beat 357.1
Sep. 30 2023 0.04 0.05 0.06 Beat 33.3
Jun. 30 2023 -0.02 -0.02 0.00 Beat 100
Mar. -0.08 -0.09 -0.06 Beat 30.8
31 2023
Dec. 31 2022 -0.04 -0.04 -0.02 Beat 45.5
Sep. 30 2022 -0.07 -0.08 -0.09 Missed -16.1
Jan. 1 0001 -0.05 -0.06 -0.11 Missed -94.1
This summary was machine generated July 29 at 21:06 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)